Breakout stocks, BHEL, Glenmark pharma
Table of Contents
BHEL Share Price
*BHEL in focus
Company is lowest bidder in DVC – Raghunathpur Thermal Power Station, WEST BENGAL Order value of >6500CR
The stock is trading below 25% from the high it touched in July 2024.
In Sept 2024 quarter, BHEL registered growth in revenues, operating profit and net profit, both QoQ & YoY.
-Sales
Sept 2023 – 5,125 Crs
June 2024 – 5,485 Crs
Sept 2024 – 6,584 Crs
Net Profit
Sept 2023 – -63 Crs
June 2024 – -211 Crs
Sept 2024 – 106 Crs
Glenmark Pharma Share Price
GLENMARK PHARMA: ICHNOS GLENMARK INNOVATION presents first clinical data from phase 1 study of TRISPECIFIC TREAT™ ANTIBODY, ISB 2001, showing high overall response rate with durable responses and favorable safety profile in patients with heavily pretreated MULTIPLE MYELOMA
In Sept 2024, FIIs added more than 2 percent stake in Glenmark Pharma.
FIIs currently hold 23.05 percent stake in the company.
In March 2024, DIIs added more than 2 percent stake in the company.
The stock has corrected close to 15 percent from its peak.
Tejas Networks Share Price
Company has posted good results in Sept 2024 quarter, both on revenues and net profit front.
Famous investor ‘Vijay Kedia‘ holds a stake in the company.
Sales
Sept 2023 – 396 Crs
June 2024 – 1,563 Crs
Sept 2024 – 2,811 Crs
Net Profit
Sept 2023 – -13 Crs
June 2024 – 77 Crs
Sept 2024 – 275 Crs
Tantia Constructions Ltd Share Price
One important point about this stock is that promoters added more than 36 percent stake in the company in Dec 2023 quarter and now hold more than 94 percent stake.
Agarwal Industrial Corporation Ltd Share Price
This Ashish Kacholia portfolio stock has been trading in a range for about 6 months.
It has given a breakout above 1235.
Its PE-EPS chart is showing a good story. Its TTM EPS is at an all time high. It’s PE is below it’s respective industry PE.
FII/FPI have decreased holdings from 5.97% to 5.51% in Sep 2024 quarter.
Number of FII/FPI investors increased from 8 to 16 in Sep 2024 quarter.
Dr Reddy Laboratories Share Price
DIIs have been buying the stock for last 3 quarters.
102 MFs bought and 20 MFs sold Dr. Reddy’s Laboratories Ltd. in the month of Nov 2024 for a net change of 457,833 stocks
ICICI Prudential Bluechip Fund Growth was the highest buyer of 627,745 shares in Nov 2024 constituting 0.08% of the paid up equity of the company.
Kotak Equity Arbitrage Fund Growth was the highest seller of 2,323,750 shares in Nov 2024 constituting 0.28% of the paid up equity of the company.
NLC India Share Price
DIIs have been adding their stake in the company for last 3 quarters.
Mutual Funds have increased holdings from 9.23% to 9.94% in Sep 2024 quarter.
Number of MF schemes increased from 15 to 20 in Sep 2024 quarter.
Nippon India Power & Infra Fund – Growth was the highest buyer of 910,833 shares in Nov 2024 constituting 0.07% of the paid up equity of the company.
Aditya Birla Sun Life Pure Value Fund Growth was the highest seller of 772,942 shares in Nov 2024 constituting 0.06% of the paid up equity of the company.
FII/FPI have increased holdings from 2.18% to 2.53% in Sep 2024 quarter.
Number of FII/FPI investors increase from 149 to 151 in Sep 2024 quarter.